Correlation Between Regenxbio and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Denali Therapeutics, you can compare the effects of market volatilities on Regenxbio and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Denali Therapeutics.
Diversification Opportunities for Regenxbio and Denali Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Regenxbio and Denali is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Regenxbio i.e., Regenxbio and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Regenxbio and Denali Therapeutics
Given the investment horizon of 90 days Regenxbio is expected to generate 1.64 times more return on investment than Denali Therapeutics. However, Regenxbio is 1.64 times more volatile than Denali Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Denali Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 892.00 in Regenxbio on September 6, 2024 and sell it today you would earn a total of 38.00 from holding Regenxbio or generate 4.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 95.45% |
Values | Daily Returns |
Regenxbio vs. Denali Therapeutics
Performance |
Timeline |
Regenxbio |
Denali Therapeutics |
Regenxbio and Denali Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regenxbio and Denali Therapeutics
The main advantage of trading using opposite Regenxbio and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
Denali Therapeutics vs. Candel Therapeutics | Denali Therapeutics vs. Cingulate Warrants | Denali Therapeutics vs. Unicycive Therapeutics | Denali Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Valuation Check real value of public entities based on technical and fundamental data |